Just caught a TV ad for a new product approved by FDA for treatment of papules and pustules of rosacea. It is expressly, however, not yet deemed effective for the "redness" of rosacea, (which is often the result of telangiectasia, or the expansion of capillaries that we sometimes see on the face and eyelid margins). The Oracea formula is a relatively low-dose capsule containing both regular and slow-release doxycycline, for a total of about 40 mg, taken once daily for facial rosacea.
Wanted to flag this for those who have had success in the treatment of MGD and/or ocular rosacea with doxycycline here, because this formulation might turn out to be a good bang for the buck (not financially, perhaps, but in terms of the possibility that one could take a relatively low dose of this antibiotic, and get a more-than-usual effect because of its time-release component).
If anyone tries this new product for MGD and/or ocular rosacea, I would be very interested in reading about experiences with it, here.
I haven't been on doxycycline for quite a few years, now, and do not plan to return to it, but I know how helpful this medication has been for some here at DEZ, and am hopeful that Oracea may possibly present a new option for eye docs to try, in appropriate cases.
Wanted to flag this for those who have had success in the treatment of MGD and/or ocular rosacea with doxycycline here, because this formulation might turn out to be a good bang for the buck (not financially, perhaps, but in terms of the possibility that one could take a relatively low dose of this antibiotic, and get a more-than-usual effect because of its time-release component).
If anyone tries this new product for MGD and/or ocular rosacea, I would be very interested in reading about experiences with it, here.
I haven't been on doxycycline for quite a few years, now, and do not plan to return to it, but I know how helpful this medication has been for some here at DEZ, and am hopeful that Oracea may possibly present a new option for eye docs to try, in appropriate cases.
Comment